Fast 50.000 Menschen in der Schweiz haben eine von uns lancierte Petition unterzeichnet und fordern ein Mitspracherecht bei der Erhöhung der Krankenkassenprämien. Die nun dem Parlament vorgelegte Petition fordert, dass diejenigen, die jedes Jahr Milliarden zahlen, in Preisverhandlungen vertreten werden, die derzeit hinter verschlossenen Türen von Versicherern, Krankenhäusern und Ärzten geführt werden.
https://www.beobachter.ch/gesundheit/schluss-mit-geheim-verhandlungen-beobachter-ubergibt-die-pramien-petition-931317
Von beobachtermagazin
7 Kommentare
This is the problem with socialist healthcare systems
Why not an initiative instead of a petition?
Imo this would be the main benefit of nationalising the insurances. Now it’s only private actors battling out who of them can increase their profits the most but we have to pay the bill while politics watches from the sideline.
This also creates a great system where nobody is responsible.
I would rather have healthcare experts negotiate the TARMED prices. But with all healthcare from 2028 being partly canton-financed, hopefully we can push that lever further, so the cantons contribute more and premium payers pay less directly (benefiting from a greater progressive vs flat cost sharing).
These petitions are useless. You want to have good healthcare cheap almost costing you nothing? Let’s see how is that in the countries where there’s “free” healthcare system? 👀
Costs rising, so for car parts hence the expensive insurance premiums for cars as well.
Healthcare the same. And still some hospitals barely can have profit. It’s still cheaper compared to the quality.
Problem is less with the healthcare providers – and more with people demanding plus medical system offering all sorts of expensive treatments.
We WANT those things. And someone has to pay for them.
Sure, there is room for optimization. Like, parallel imports of drugs. Yet, the ultimate root cause is simply that people want expensive medicine. What’s perverse is that drug manufacturers often do not even have any incentive to bring down costs. The costs for their suboptimal production are ultimately being paid by consumers. Some specialized drugs have insane margins (speaking 1000 USD per pill) – others not so much.
So, the discussion how to bring down costs will remain very challenging, cause, of course, when you have some health issues you do not want to be told that „Sorry, your treatment exceeds our budget.“
Awesome! It’s a good first step.